Item(by='knowaveragejoe', descendants=None, kids=[25863223], score=None, time=1611257593, title=None, item_type='comment', url=None, parent=25862947, text='The next section in the article is what&#x27;s important here:<p>E484K mutation\nThe E484K amino acid change, a receptor-binding-domain (RBD) mutation, was reported to be &quot;associated with escape from neutralising antibodies&quot; which could adversely affect the efficacy of spike protein-dependent COVID vaccines.[50][51] The E484K spike mutation was linked to a case of reinfection with the 501.V2 variant of SARS-CoV-2 in Brazil, believed by researchers to be the first such case of reinfection involving this mutation.[29] The possibility of an alteration in antigenicity was referred to as an &quot;escape mutation&quot; from a monoclonal antibody with the capability of neutralising the spike protein variants of SARS-CoV-2.[52][53]')